78
Views
8
CrossRef citations to date
0
Altmetric
Letter to the Editor

Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase

, , , , , , , & show all
Pages 1427-1430 | Received 02 Dec 2005, Accepted 20 Jan 2006, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yi Ling Teo, Han Kiat Ho & Alexandre Chan. (2015) Formation of reactive metabolites and management of tyrosine kinase inhibitor-induced hepatotoxicity: a literature review. Expert Opinion on Drug Metabolism & Toxicology 11:2, pages 231-242.
Read now

Articles from other publishers (7)

Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano & Aileen Wee. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver 842 946 .
Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano & Aileen Wee. 2018. Macsween's Pathology of the Liver. Macsween's Pathology of the Liver 780 879 .
Lars Harbaum, Andreas Marx, Eray Goekkurt, Philippe Schafhausen & Djordje Atanackovic. (2013) Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity. International Journal of Hematology 99:1, pages 91-94.
Crossref
Zachary D. Goodman, Luigi M. Terracciano & Aileen Wee. 2012. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver 761 851 .
E Jabbour, M Deininger & A Hochhaus. (2010) Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. Leukemia 25:2, pages 201-210.
Crossref
Amani Asnacios, Sylvie Naveau & Gabriel Perlemuter. (2009) Gastrointestinal toxicities of novel agents in cancer therapy. European Journal of Cancer 45, pages 332-342.
Crossref
Francisco Fuster, Luis Medina, Rolando Vallansot, Miquel Granell & Miquel Bruguera. (2007) Hepatitis tóxica por imatinib: descripción de dos casos y revisión de la literatura médica. Gastroenterología y Hepatología 30:9, pages 525-529.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.